Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference

Although opioids are widely used to treat moderate to severe pain, opioid addiction and the opioid overdose epidemic are becoming more serious. Although opioid receptor antagonists/partial agonists, such as naltrexone and buprenorphine, have relatively low selectivity for the μ-opioid receptor (MOP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ide, Soichiro, Iwase, Noriaki, Arai, Kenichi, Kojima, Masahiro, Ushiyama, Shigeru, Taniko, Kaori, Ikeda, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961271/
https://www.ncbi.nlm.nih.gov/pubmed/36834763
http://dx.doi.org/10.3390/ijms24043351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961271/
https://www.ncbi.nlm.nih.gov/pubmed/36834763
http://dx.doi.org/10.3390/ijms24043351

Ejemplares similares